The moderate to severe atopic dermatitis market is experiencing strong growth driven by rising global prevalence and heightened awareness, fueling de ...

Patients with atopic dermatitis had an increased risk for COVID-19 infection despite age and sex, and some comorbidities were linked to a greater risk.

The findings, which add to the limited data on the burden of atopic dermatitis on adolescent and pediatric patients, showed ...

The American Academy of Pediatrics recommends moisturization, topical anti-inflammatories, and certain systemic medications for pediatric AD.

Discover a study that discussed how mental health issues such as anxiety and depression are common comorbidities in people ...

In a clinical report published online May 19 in Pediatrics, the American Academy of Pediatrics presents updated guidance for the treatment of children with atopic dermatitis (AD). Noting that many ...

Background: Atopic dermatitis (AD) patients have sensitive skin with impaired barrier function. Lyocell is a cellulosic fiber that offers unique characteristics and may be suitable for use by AD ...

Allergic skin diseases, such as atopic dermatitis and chronic spontaneous urticaria, are among the most prevalent and ...

Pfizer could be just a few months away from getting FDA approval for its JAK1 inhibitor abrocitinib in atopic dermatitis, a drug that CEO Albert Bourla believes hasn’t been given the credit it ...

After a couple of days filled with investor nervousness, Arcutis Biotherapeutics has claimed FDA approval of Zoryve for the new indication of atopic dermatitis (AD), a common form of eczema.